Efficacy and Prognosis in Patients with Papillary Thyroid Cancer with Postoperative Preablative Stimulated Thyroglobulin above 10 ng/mL after Initial Therapy with Radioiodine
Acta Endocrinologica (Bucharest) · 2024 · 20 (2) · 186-192
DOI: 10.4183/aeb.2024.186 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Endocrinologica (Bucharest), 2024. Verfasst von L Luo und 3 weiteren Autor:innen. Beteiligte Einrichtung: The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China - Department of Nuclear …. Die Arbeit wurde bisher 1-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- The First Affiliated Hospital of USTC, Division of Life Sciences and Medicine, University of Science and Technology of China - Department of Nuclear Medicine, Hefei, Anhui, China.
Zitieren
APA
Luo, L., Xia, J., Zhang, R., & Yao, X. (2024). Efficacy and Prognosis in Patients with Papillary Thyroid Cancer with Postoperative Preablative Stimulated Thyroglobulin above 10 ng/mL after Initial Therapy with Radioiodine. Acta Endocrinologica (Bucharest), 20(2), 186-192. https://doi.org/10.4183/aeb.2024.186
Vancouver
Luo L, Xia J, Zhang R, Yao X. Efficacy and Prognosis in Patients with Papillary Thyroid Cancer with Postoperative Preablative Stimulated Thyroglobulin above 10 ng/mL after Initial Therapy with Radioiodine. Acta Endocrinologica (Bucharest). 2024;20(2):186-192. doi:10.4183/aeb.2024.186
BibTeX
@article{Luo2024,
author = {Luo, L and Xia, J and Zhang, R and Yao, X},
title = {Efficacy and Prognosis in Patients with Papillary Thyroid Cancer with Postoperative Preablative Stimulated Thyroglobulin above 10 ng/mL after Initial Therapy with Radioiodine},
journal = {Acta Endocrinologica (Bucharest)},
year = {2024},
volume = {20},
number = {2},
pages = {186--192},
doi = {10.4183/aeb.2024.186}
}
EUVIMED